HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Noda Selected Research

K Noda Research Topics

Disease

20Neoplasms (Cancer)
05/2019 - 03/2000
5Neutropenia
10/2010 - 06/2000
5Lung Neoplasms (Lung Cancer)
02/2009 - 05/2000
5Neoplasm Metastasis (Metastasis)
07/2001 - 11/2000
4Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2014 - 01/2000
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2010 - 05/2000
3Thrombosis (Thrombus)
04/2001 - 10/2000
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2014 - 01/2000
2Inflammation (Inflammations)
11/2012 - 02/2007
2Thrombocytopenia (Thrombopenia)
10/2010 - 06/2000
2Thymoma (Thymic Carcinoma)
06/2010 - 11/2009
2Endometrial Neoplasms (Endometrial Cancer)
10/2005 - 10/2001
2Hepatocellular Carcinoma (Hepatoma)
07/2002 - 05/2001
2Microsatellite Instability
10/2001 - 09/2001
2Ovarian Neoplasms (Ovarian Cancer)
09/2001 - 12/2000
2Melanoma (Melanoma, Malignant)
09/2001 - 01/2001
2Leukopenia
07/2001 - 06/2000
2Infections
07/2001 - 02/2001
2Carcinoma (Carcinomatosis)
05/2001 - 01/2000
2Atherosclerosis
04/2001 - 11/2000
2Myocardial Infarction
02/2001 - 09/2000
1Hyperalgesia
03/2015
1Pain (Aches)
03/2015
1Hyperkinesis
03/2015
1Disease Progression
05/2014
1Diabetic Retinopathy (Retinopathy, Diabetic)
11/2012
1Vision Disorders (Hemeralopia)
05/2010
1Ganglion Cysts (Ganglion)
05/2010
1Pericardial Effusion
02/2009
1Experimental Arthritis
11/2007
1Arthritis (Polyarthritis)
11/2007
1Leukostasis
02/2007
1Uveitis
02/2007
1Eye Diseases (Eye Disease)
02/2007
1Lymphopenia (Lymphocytopenia)
12/2006
1Glucose Intolerance
10/2004
1Insulin Resistance
10/2004
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2003
1Anorexia
05/2002
1Vomiting
05/2002

Drug/Important Bio-Agent (IBA)

7Cisplatin (Platino)FDA LinkGeneric
06/2010 - 01/2000
4IsotopesIBA
05/2019 - 12/2015
4PlatinumIBA
10/2010 - 05/2000
3Irinotecan (Camptosar)FDA LinkGeneric
10/2010 - 01/2000
3Glucose (Dextrose)FDA LinkGeneric
10/2004 - 12/2000
2IonsIBA
05/2019 - 11/2018
2Immunologic Factors (Immunomodulators)IBA
05/2014 - 11/2000
2Retinaldehyde (Retinal)IBA
11/2012 - 02/2007
2Etoposide (VP 16)FDA LinkGeneric
06/2010 - 05/2003
2Proteins (Proteins, Gene)FDA Link
02/2007 - 05/2001
2Docetaxel (Taxotere)FDA Link
10/2005 - 12/2000
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
07/2002 - 07/2001
2LectinsIBA
07/2002 - 03/2001
2Adrenal Cortex Hormones (Corticosteroids)IBA
12/2001 - 07/2001
2Progesterone Receptors (Progesterone Receptor)IBA
10/2001 - 07/2001
2Estrogen ReceptorsIBA
10/2001 - 07/2001
2Peptides (Polypeptides)IBA
07/2001 - 07/2000
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
07/2001 - 06/2000
2ErbB Receptors (EGF Receptor)IBA
07/2001 - 05/2001
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
04/2001 - 11/2000
2doxifluridineIBA
03/2001 - 03/2001
2Polysaccharides (Glycans)IBA
03/2001 - 01/2001
2lipoprotein-associated coagulation inhibitor (TFPI)IBA
10/2000 - 09/2000
1CarbonIBA
08/2015
1Oxidopamine (6 Hydroxydopamine)IBA
03/2015
1Formaldehyde (Formol)FDA Link
03/2015
1Dopamine (Intropin)FDA LinkGeneric
03/2015
1Methamphetamine (Desoxyn)FDA LinkGeneric
03/2015
1specific substance maruyama (Z-100)IBA
05/2014
1Prorenin ReceptorIBA
11/2012
1nedaplatinIBA
10/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2010
1Vincristine (Oncovin)FDA LinkGeneric
06/2010
1LuteinIBA
05/2010
1Bleomycin (Blenoxane)FDA LinkGeneric
02/2009
1Collagen Type II (Type II Collagen)IBA
11/2007
1EndostatinsIBA
11/2007
1Dihydrotachysterol (AT 10)IBA
11/2007
1Angiogenesis InhibitorsIBA
11/2007
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
02/2007
1EndotoxinsIBA
02/2007
1Integrin alpha4beta1 (VLA-4)IBA
02/2007
1IntegrinsIBA
02/2007
1Hydrocortisone (Cortisol)FDA LinkGeneric
12/2006
12,4-thiazolidinedione (thiazolidinedione)IBA
10/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2004
1ResistinIBA
10/2004
13,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA
07/2002
1FucosyltransferasesIBA
07/2002
1Pharmaceutical PreparationsIBA
07/2002
1Culture MediaIBA
07/2002
1ramosetron (Nasea)IBA
05/2002

Therapy/Procedure

12Therapeutics
05/2019 - 02/2001
10Drug Therapy (Chemotherapy)
10/2010 - 01/2000
5Radiotherapy
05/2014 - 03/2001
2Immunotherapy
03/2001 - 03/2001
1Synchrotrons
08/2015
1Secondary Prevention
07/2002
1Aftercare (After-Treatment)
07/2002
1Injections
05/2002